| 今开：4.99 | 昨收：5.05 |
| 最高：5.06 | 最低：4.905 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.25376863E8 |
Allogene疗法(ALLO)2020-03-21 04:45
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-002807 Size: 5 KB 网页链接查看全文
chuminhua2020-05-30 00:00
5/29，ASCO：Allogene$Allogene疗法(ALLO)$ 报告了其通用型CD19 CAR-T疗法ALLO-501用于22名淋巴瘤患者的数据。ALLO-501和抗体ALLO-647联用，治疗22名患者，19例进行了疗效分析。7个CR，5个PR，12名有响应的患者中9名在将近4个月的中位随访期内未复发。接受更高剂量ALLO-647的患者中50%达到CR。ALLO...查看全文
Allogene疗法(ALLO)2020-03-12 04:45
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-002528 Size: 6 KB 网页链接查看全文
Allogene疗法(ALLO)2020-03-19 04:40
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-002735 Size: 8 KB 网页链接查看全文
chuminhua2020-05-15 12:21
5/13，#ASCO2020#，Allogene Therapeutics公司$Allogene疗法(ALLO)$ 宣布，将在ASCO年会上公布其“即用型”CAR-T疗法ALLO-501在治疗复发/难治性非霍奇金淋巴瘤（R/R NHL）的1期剂量递增试验中的最新结果。摘要指出，截至2020年1月，总计9名R/R NHL患者接受了ALLO-501的治疗。安全性研究没有发现限...查看全文
Allogene疗法(ALLO)2020-02-28 05:20
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-20-000012 Act: 34 Size: 15 MB 网页链接查看全文
Allogene疗法(ALLO)2021-06-12 05:51
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-21-006504 Size: 6 KB 网页链接查看全文
Allogene疗法(ALLO)2021-06-12 07:34
$Allogene疗法(ALLO)$ 内部交易: 2021-06-09,Director,WITTE OWEN N. ,卖出,9969普通股, $25.05查看全文
Allogene疗法(ALLO)2021-06-12 05:51
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-21-006499 Size: 4 KB 网页链接查看全文
Allogene疗法(ALLO)03-25 08:27
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000529 Size: 7 KB 网页链接查看全文
Allogene疗法(ALLO)03-25 08:21
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000523 Size: 10 KB 网页链接查看全文
Allogene疗法(ALLO)03-25 08:21
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000527 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)03-25 08:21
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000525 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-25 08:18
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000521 Size: 10 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 05:36
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 05:12
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:57
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:51
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-11 05:06
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000529 Size: 7 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000523 Size: 10 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000525 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000527 Size: 8 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000521 Size: 10 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接